Triiodothyronine (T3) induces HIF1A and TGFA expression in MCF7 cells by activating PI3K

• Published in: Life sciences (1973) Vol. 154; pp. 52 - 57
• Main Authors: Moretto, Fernanda Cristina Fontes, De Sibio, Maria Teresa, Luvizon, Aline Carbonera, Olimpio, Regiane Marques Castro, de Oliveira, Miriane, Alves, Carlos Augusto Barnabe, Conde, Sandro José, Nogueira, Célia Regina
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-06-2016
• Subjects: Breast cancer; Enzyme Activation; Extra-nuclear pathway; Gene expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit - genetics; MCF-7 Cells; Phosphatidylinositol 3-Kinases - metabolism; Thyroid hormone; Transforming Growth Factor alpha - genetics; Triiodothyronine - physiology; Thyroid hormone; Breast cancer; Gene expression; Extra-nuclear pathway
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2016.04.024

High expression levels of hypoxia inducing factor 1 alpha are related to mammary carcinogenesis. In previous studies, we demonstrated that expression of transforming growth factor alpha increases upon treatment with triiodothyronine, but this expression does not occur in cellular models that do not express the estrogen receptor, or when cells are co-treated with the anti-estrogen, tamoxifen. The aim of this study was to determine the effect of the hormone triiodothyronine on the expression of the genes HIF1A and TGFA in the breast cancer cell line MCF7. The cell line was subjected to treatment with triiodothyronine at the supraphysiological dose of 10−8M for 10min, 30min, 1h, and 4h in the presence or absence of actinomycin D, the gene expression inhibitor, cycloheximide, the protein synthesis inhibitor, and LY294002, the phosphoinositide 3 kinase inhibitor. HIF1A and TGFA mRNA expression was analyzed by reverse transcription polymerase chain reaction. For data analysis, we used analysis of variance complemented by Tukey test and an adopted minimum of 5% significance. We found that HIF1A and TGFA expression increased in the presence of triiodothyronine at all times studied. HIF1A expression decreased in triiodothyronine-treated cells when gene transcription was also inhibited; however, TGFA expression decreased after 10 and 30min of treatment even when transcription was not inhibited. We found that activation of PI3K was necessary for triiodothyronine to modulate HIF1A and TGFA expression.